Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA REFORM LEGISLATION UNLIKELY TO PASS HOUSE THIS YEAR, REP. PALLONE SAYS; SEN. WYDEN PUSHING HIS HOUSE APPROACH TO INFORMATION DISSEMINATION IN SENATE

This article was originally published in The Gray Sheet

Executive Summary

FDA reform legislation is unlikely to pass the House this year, Rep. Frank Pallone (D-N.J.) told the National Association of Retail Druggists' legislative conference April 23 in Washington, D.C. "I think you are going to see hearings, and you are going to see a lot of effort to come to a consensus this year, but I would doubt very much that you will see a bill pass the House on FDA reform" this session, Pallone said. "I think that what we are doing now is basically trying to come up with language and a framework that we can move on in the next" session, he added.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005859

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel